EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France. - Boussahoua, M; Sutherland, CS; Aponte Ribero, V; Enache, R; Le Lay, K; Le Dissez, C; Chevalier, J (Value in Health, 2022)